Literature DB >> 9329506

Combination therapies for HIV infection and genomic drug resistance.

D Katzenstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9329506     DOI： 10.1016/s0140-6736(97)22040-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Antimicrobial resistance--pharmacological solutions.

Authors:  E Rubinstein
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 2.  Didanosine: an updated review of its use in HIV infection.

Authors:  C M Perry; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Upgrading antibiotic use within a class: tradeoff between resistance and treatment success.

Authors:  Y Claire Wang; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-13       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.